These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39088077)

  • 1. Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases.
    Wang J; Liu L; Li J; Feng X; Yi H; Jiang E; Zheng Y; Zhang F; Zhu X; Mi Y; Han M; Wang J; Feng S
    Mycopathologia; 2024 Aug; 189(4):71. PubMed ID: 39088077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary management and clinical outcomes of mucormycosis: A systematic review and meta-analysis of case reports.
    Jeong W; Keighley C; Wolfe R; Lee WL; Slavin MA; Chen SC; Kong DCM
    Int J Antimicrob Agents; 2019 May; 53(5):589-597. PubMed ID: 30639526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nasal and cutaneous mucormycosis in two patients with lymphoma after chemotherapy and target therapy: Early detection by metagenomic next-generation sequencing.
    Zhang Q; Liu X; Liu Y; Wang H; Zhao R; Lv X; Wei X; Zhou K
    Front Cell Infect Microbiol; 2022; 12():960766. PubMed ID: 36189372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical analysis of 3 cases of mucormycosis in children with acute lymphoblastic leukemia and literature review].
    Sun HY; Li B; Liu Y; You HL; Liu YF
    Zhonghua Er Ke Za Zhi; 2022 Jan; 60(1):56-61. PubMed ID: 34986625
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical features of pediatric mucormycosis: role of metagenomic next generation sequencing in diagnosis.
    Zhang Y; Wei E; Niu J; Yan K; Zhang M; Yuan W; Fang X; Jia P
    Front Cell Infect Microbiol; 2024; 14():1368165. PubMed ID: 38915923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucormycosis in hematologic patients.
    Pagano L; Offidani M; Fianchi L; Nosari A; Candoni A; Picardi M; Corvatta L; D'Antonio D; Girmenia C; Martino P; Del Favero A;
    Haematologica; 2004 Feb; 89(2):207-14. PubMed ID: 15003897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
    Lanternier F; Dannaoui E; Morizot G; Elie C; Garcia-Hermoso D; Huerre M; Bitar D; Dromer F; Lortholary O;
    Clin Infect Dis; 2012 Feb; 54 Suppl 1():S35-43. PubMed ID: 22247443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial use of combination treatment does not impact survival of 106 patients with haematologic malignancies and mucormycosis: a propensity score analysis.
    Kyvernitakis A; Torres HA; Jiang Y; Chamilos G; Lewis RE; Kontoyiannis DP
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e1-811.e8. PubMed ID: 27085727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy.
    Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F
    Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful nonoperative management of gastrointestinal mucormycosis: novel therapy for invasive disease.
    Mezhir JJ; Mullane KM; Zarling J; Satoskar R; Pai RK; Roggin KK
    Surg Infect (Larchmt); 2009 Oct; 10(5):447-51. PubMed ID: 19485785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pulmonary mucormycosis: report of 5 cases and review of 46 cases reported in China].
    Yang YM; Fang BM; Xu XM; Fang F; Pan MM; Zhong XF; Sun TY
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):572-6. PubMed ID: 24252732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality in hematologic malignancy and hematopoietic stem cell transplant patients with mucormycosis, 2001 to 2009.
    Hammond SP; Baden LR; Marty FM
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5018-21. PubMed ID: 21876046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expert consensus on diagnosis and treatment of severe COVID-19 associated pulmonary
    ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Jan; 47(1):10-23. PubMed ID: 38062689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mucormycosis: retrospective evaluation of 12 cases].
    Arda B; Erdem A; Sipahi OR; Işıkgöz Taşbakan M; Pullukçu H; Taşbakan MS; Ceylan N; Metin DY; Midilli R; Yamazhan T; Ulusoy S
    Mikrobiyol Bul; 2011 Jul; 45(3):504-11. PubMed ID: 21935783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple diagnostic methods for mucormycosis: A retrospective case series.
    Wang J; Wang Y; Han F; Chen J
    J Clin Lab Anal; 2022 Aug; 36(8):e24588. PubMed ID: 35792018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of disseminated mucormycosis with a combination of liposomal amphotericin B and posaconazole in a patient with acute myeloid leukaemia.
    Rickerts V; Atta J; Herrmann S; Jacobi V; Lambrecht E; Bialek R; Just-Nübling G
    Mycoses; 2006; 49 Suppl 1():27-30. PubMed ID: 16961579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of metagenomic next⁃generation sequencing in infectious diseases.
    Duan H; Li X; Mei A; Li P; Liu Y; Li X; Li W; Wang C; Xie S
    BMC Infect Dis; 2021 Jan; 21(1):62. PubMed ID: 33435894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn).
    Salmanton-García J; Seidel D; Koehler P; Mellinghoff SC; Herbrecht R; Klimko N; Ráčil Z; Falces-Romero I; Ingram P; Benítez-Peñuela MÁ; Rodríguez JY; Desoubeaux G; Barać A; García-Vidal C; Hoenigl M; Mehta SR; Cheng MP; Klyasova G; Heinz WJ; Iqbal N; Krause R; Ostermann H; Penack O; Schalk E; Sheppard DC; Willinger B; Wisplinghoff H; Vehreschild JJ; Cornely OA; Vehreschild MJGT;
    J Antimicrob Chemother; 2019 Nov; 74(11):3315-3327. PubMed ID: 31393591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability in the cumulative incidence, severity and mortality of 101 cases of invasive mucormycosis in high-risk patients from 1995 to 2011: a comparison of eras immediately before and after the availability of voriconazole and echinocandin-amphotericin combination therapies.
    Abidi MZ; Sohail MR; Cummins N; Wilhelm M; Wengenack N; Brumble L; Shah H; Jane Hata D; McCullough A; Wendel A; Vikram HR; Kusne S; Litzow M; Letendre L; Lahr BD; Poeschla E; Walker RC
    Mycoses; 2014 Nov; 57(11):687-98. PubMed ID: 25040241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview and outcome of mucormycosis among children with cancer: Report from the Children's Cancer Hospital Egypt.
    Madney Y; Khedr R; Ahmed N; El-Mahallawy H; Youssef A; Taha H; Hassanain O; Ahmed G; Hafez H
    Mycoses; 2019 Nov; 62(11):984-989. PubMed ID: 30983046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.